Just two days after Democrat Joe Biden was declared the winner of the 2020 presidential election, drugmaker Pfizer announced ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Healthcare stocks have been out of vogue with investors since late 2022. Myriad reasons underlie the negative sentiment ...

The inquiry is looking into a politically explosive suggestion that Pfizer delayed announcing a successful vaccine against ...

The drugmaker has revamped how it packages, promotes and sells certain medicines in an effort to overcome a postpandemic ...

With the market underpricing its earnings stability and future catalysts, Pfizer presents a compelling defensive investment ...

The PMCPA has dug into the industry’s LinkedIn activities once again. | The PMCPA has dug into the industry’s LinkedIn ...

Pfizer sells entire Haleon stake for $3.24 billion ... Drugmakers agree to participate in second round of price negotiations All drug manufacturers, including Novo Nordisk and Teva Pharmaceuticals ...

Biotech company Immunai, which developed an AI-based immune system mapping technology for drug development, announces the ...

The FDA has approved a new drug for a serious heart condition that affects thousands of people. The drug, called Amvuttra ...